Abstract
Lack of detectable expression of p27kip1 cyclin dependent kinase inhibitor has previously been correlated with high degree of malignancy in human breast, colorectal, gastric and small cell lung carcinomas. Here we demonstrate that an inverse correlation between p27kip1 expression and tumour malignancy also exists in most types of human B cell lymphomas examined. A clear exception was Burkitt's lymphoma (BL), a highly malignant tumour which often expresses high levels of p27kip1. Analysis of p27kip1 derived from Burkitt's lymphoma cell lines expressing high levels of p27kip1, BL40 and BL41, in a cyclin E/cdk2 kinase inhibition assay demonstrated that p27kip1 is not permanently inactivated since heat treatment can restore the inhibitory activity of p27kip1. However, p27kip1 expressed in these two cell lines is largely sequestered in inactive complexes and we have no evidence that c-myc or Epstein-Barr virus are responsible for the sequestration of p27kip1 in these two cell lines although c-myc and EBV are two oncogenic agents often associated with Burkitt's lymphomas. Interestingly, we observed that high level p27kip1 expression often correlated with cyclin D3 overexpression both in vivo and in BL cell lines. The majority of p27kip1 in BL40 cells was complexed with cyclin D3 indicating that overexpressed cyclin D3 may at least be part of the sequestering activity for the inhibitory function of p27kip1. Furthermore, cyclinD3/cdk4 complex could sequester p27kip1 in a cyclin E/cdk2 kinase assay in vitro. Finally, we show that cyclin D3 transfected into an inducible p27kip1 cell line could overcome the G1 arrest mediated by p27kip1. These results argue that in addition to down-regulation of p27kip1 expression, some tumour cells can sequester and tolerate the antiproliferative function of p27kip1. They also suggest a novel role for the overexpression of D-type cyclins as one pathway allowing tumour cells to overcome the antiproliferative function of p27kip1.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bartkova J, Zemanova M and Bartek J. . 1996 Int. J. Cancer 65: 323–327.
Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts HM and Sherr CJ. . 1999 EMBO J. 18: 1571–1583.
Elledge SJ and Harper JW. . 1994 Curr. Opin. Cell Biol. 6: 847–852.
Fero ML, Randel E, Gurley KE, Roberts JM and Kemp CJ. . 1998 Nature 396: 177–180.
Fero ML, Rivkin M, Tasch M, Porter P, Carcow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, Kaushansky K and Roberts J. . 1996 Cell 85: 733–744.
Firpo EJ, Koff A, Solomon MJ and Roberts JM. . 1994 Mol. Cell. Biol. 14: 4889–4901.
Fredersdorf S, Burns J, Milne AM, Packham G, Fallis L, Lu X, et al. 1997 Proc. Natl. Acad. Sci. USA 94: 6380–6385.
Godden-Kent D, Talbot S, Boshoff C, Chang Y, Moore P, Weiss RA and Mittnacht S. . 1997 J. Virol. 71: 4193–4198.
Harlow EE and Lane DP. . 1988 Antibodies: A laboratory manual. Cold Spring Harbor Laboratory Press, New York.
Hsieh J-K, Fredersdorf S, Kauzarides T, Martin K and Lu X. . 1997 Genes Dev. 11: 1840–1852.
Kato J, Matsuoka M, Polyak K, Massague M and Sherr C. . 1994 Cell 79: 487–496.
Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA and Koff A. . 1996 Cell 85: 721–732.
Lloyd RV, Erickson LA, Jin L, Kulig E, Qian X, Cheville JC and Scheithauer BW. . 1999 Am. J. Pathol. 154: 313–323.
Mal A, Poon RYC, Howe PH, Toyoshima H, Hunter T and Harter M. . 1996 Nature 380: 262–265.
Matsushime H, Ewen ME, Strom DK, Kato JY, Hanks SK, Roussel MF and Sherr CJ. . 1992 Cell 16: 323–334.
Muller D, Bouchard C, Rudolph B, Steiner P, Stuckmann I, Saffrich R, Ansorge W, Huttner W and Eilers M. . 1997 Oncogene 15: 2561–2576.
Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido M, Horii I, Loh DY and Nakayama K. . 1996 Cell 85: 707–720.
Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee MH, Massague J, Crabtree GR and Roberts JM. . 1994 Nature 372: 570–573.
Polyak K, Kato J, Solomon MJ, Sherr CJ, Massague J, Roberts JM and Koff A. . 1994a Genes Dev. 8: 9–22.
Polyak K, Lee M, Erdjument-Bromaga H, Koff A, Roberts JM, Tempst P and Massague J. . 1994b Cell 78: 59–66.
Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR and Roberts JM. . 1997 Nature Med 3: 222–226.
Reynisdottir I, Polyak K, Iavarone A and Massague J. . 1995 Genes Dev. 9: 1831–1845.
Sanchez-Beato M, Saez AI, Martinez-Montero CJ, Mateo MS, Sanchez-Verde L, Villuendas R, Troncone G and Piris MA. . 1997 Am. J. Pathol. 151: 151–160.
Sheaff RJ, Groudinne M, Gordon M, Roberts JM and Clurman BE. . 1997 Genes Dev. 11: 1464–1478.
Sinclair A and Farrell PJ. . 1995 Methods Mol. Genet 7: 89–100.
Toyoshima H and Hunter T. . 1994 Cell 78: 67–74.
Vlach J, Hennecke S, Alevizopoulos K, Conti D and Amati B. . 1996 EMBO J. 15: 6595–6604.
Zerfass-Thome K, Zwerschke W, Mannhardt B, Tindle R, Botz JW and Jansen-Durr P. . 1996 Oncogene 13: 2323–2330.
Acknowledgements
We would like to thank Dr Gordon Peters for the rabbit polyclonal antibody for cyclin D1 and Dr Graham Packham for useful discussion. This work was supported by the Ludwig Institute for Cancer Research and Leukaemia Research Fund.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barnouin, K., Fredersdorf, S., Eddaoudi, A. et al. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells. Oncogene 18, 6388–6397 (1999). https://doi.org/10.1038/sj.onc.1203162
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203162
Keywords
This article is cited by
-
Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus – correlation with proliferation and clinicopathological parameters
British Journal of Cancer (2002)
-
Exploitation of a non-apoptotic caspase to regulate the abundance of the cdkI p27KIP1 in transformed lymphoid cells
Oncogene (2001)